BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 [PMID: 33362383 DOI: 10.3748/wjg.v26.i46.7272]
URL: https://www.wjgnet.com/1948-5182/full/v26/i46/7272.htm
Number Citing Articles
1
Takumi Umemura, Kazuki Nishikawa, Yoshikazu Mutoh, Hajime Sasano, Koji Kozaki, Tetsuya Yamada, Toshihiko Ichihara. Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child–Pugh class CJournal of Antimicrobial Chemotherapy 2021; 76(7): 1947 doi: 10.1093/jac/dkab076
2
M. Vitrone, F. Mele, E. Durante-Mangoni, R. Zampino. Drugs and liver injury: a not to be overlooked binomial in COVID-19Journal of Chemotherapy 2022; 34(4): 207 doi: 10.1080/1120009X.2021.1988203
3
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practiceWorld Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
4
Mohammed Hussien Ahmed, Hebat Allah Abdel Maksoud Ahmed, Nahla Abd el-Aziz Nosair, Asmaa Mbarak Hassan, Dalia ElSayed Sherief, Aya Mohammed Mahros. Fecal Calprotectin as a Predictor of COVID-19 SeverityJournal of Coloproctology 2021; 41(04): 361 doi: 10.1055/s-0041-1736646
5
George D Panayiotakopoulos, Dimitrios T Papadimitriou. Rifampicin for COVID-19World Journal of Virology 2022; 11(2): 90-97 doi: 10.5501/wjv.v11.i2.90
6
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng. COVID‐19‐associated liver injury: Adding fuel to the flameCell Biochemistry and Function 2023; 41(8): 1076 doi: 10.1002/cbf.3883
7
Camila Araújo Miranda, João Rodolfo Domingues Mansano, Fábio Erminio Mingatto. Ivermectin-induced toxicity in HepG2 cells and the protective effect of tetrahydrocurcumin and vitamin CDrug and Chemical Toxicology 2024; : 1 doi: 10.1080/01480545.2024.2389954
8
Faisal Inayat, Hassam Ali, Pratik Patel, Rubaid Dhillon, Arslan Afzal, Attiq Ur Rehman, Muhammad Sohaib Afzal, Laraib Zulfiqar, Gul Nawaz, Muhammad Hassan Naeem Goraya, Subanandhini Subramanium, Saurabh Agrawal, Sanjaya K Satapathy. Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United StatesWorld Journal of Virology 2023; 12(4): 221-232 doi: 10.5501/wjv.v12.i4.221
9
Gholam Reza Sivandzadeh, Hassan Askari, Ali Reza Safarpour, Fardad Ejtehadi, Ehsan Raeis-Abdollahi, Armaghan Vaez Lari, Mohammad Foad Abazari, Firoozeh Tarkesh, Kamran Bagheri Lankarani. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challengesWorld Journal of Clinical Cases 2021; 9(22): 6178-6200 doi: 10.12998/wjcc.v9.i22.6178
10
Roya Mahdavi, Zahra Akbari Jonoush, Mehri Ghafourian, Seyed Esmaeil Khoshnam, Fereshteh Nezhad Dehbashi, Maryam Farzaneh. The Effect of Remdesivir as an anti-COVID-19 Drug on Chicken Hepatocyte Enzymes; an in vitro StudyIranian Journal of Medical Microbiology 2023; 17(3): 309 doi: 10.30699/ijmm.17.3.309
11
Wen-Zheng Yuan, Tao Fu. Liver Dysfunction in COVID-19: From Onset to RecoverySeminars in Liver Disease 2022; 42(02): 151 doi: 10.1055/s-0042-1745871
12
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
13
Kimia Kardani, Azam Bolhassani, Mona Kardani, Elnaz Agi. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver DisordersJournal of Medical Microbiology and Infectious Diseases 2021; 9(3): 122 doi: 10.52547/JoMMID.9.3.122